Cargando…
Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures
Drug-induced liver injury (DILI) is one of the major reasons for termination of drug development. Due to the importance of predicting DILI in early phases of drug development, diverse in silico models have been developed to filter out DILI-causing candidates before clinical study. However, no comput...
Autores principales: | Shin, Hyun Kil, Kang, Myung-Gyun, Park, Daeui, Park, Tamina, Yoon, Seokjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034408/ https://www.ncbi.nlm.nih.gov/pubmed/32116729 http://dx.doi.org/10.3389/fphar.2020.00067 |
Ejemplares similares
-
Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrhosis
por: Shin, Hyun Kil, et al.
Publicado: (2022) -
Anti-Inflammatory Activity and ROS Regulation Effect of Sinapaldehyde in LPS-Stimulated RAW 264.7 Macrophages
por: Baek, Seung-Hwa, et al.
Publicado: (2020) -
Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
por: Xi, Lili, et al.
Publicado: (2023) -
Zika virus infection differentially affects genome-wide transcription in neuronal cells and myeloid dendritic cells
por: Park, Tamina, et al.
Publicado: (2020) -
Drug‐induced cholestasis
por: Sundaram, Vinay, et al.
Publicado: (2017)